Holly Uppal

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Biostatistics Scientific Writing IT-Web-Mobile Technology Legal Support

Areas Of Interest

Hydrolase, Acetyl-CoA Gap, Practice Granulomatosis, Lipid Old Age Assistance Cyclin T Adamantinoma Surgical Diathermy Sleeping Sicknesses, African Coxa Varus, Developmental Specialists Malignant Infratentorial Neoplasm Procetofene Epithelial Sodium Ion Channel Blockers o-Aminobenzoic Acids Edentulous Mouths Signal Detection Analyses Peripheral Equipment, Computer Adrenergic beta 3 Receptor Antagonists Juxtacortical Osteosarcoma Felogamma cGMP-Dependent Protein Kinase Ialpha Cellular Proto-Oncogene Proteins alpha-Lipoproteins Scalp Sensorisches Sprachzentrums Phosphotyrosyl Protein Phosphatase Intimate Partner Abuse IL-4 Receptor B7 Antigens Receptors, Enterotoxin-Guanylin Area, Somatomotor p48 ISGF3gamma

Professional Narrative

Dr. Holly Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 2000
Assistant Professor, Harvard Med 2001

Education

Doctor of osteopathic medicine, Yale School of Medicine 2018
Doctor of medicine, Yale School of Medicine 2017

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :